Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients

Aliment Pharmacol Ther. 1996 Apr;10(2):187-91. doi: 10.1046/j.1365-2036.1996.716896000.x.

Abstract

Aim: To assess the usefulness of early evening administration of roxatidine 150 mg as an alternative to the traditional bedtime regimen.

Methods: Twenty-four patients with healed duodenal ulcer were dosed according to a balanced incomplete-block design, with two of the following regimens: placebo, roxatidine 150 mg at 07.30 h (early evening) or roxatidine 150 mg at 22.00 h (bedtime). Twenty-four-hour intragastric pH-metry was started at 18.00 h on the first day of dosing. Median pH was determined for the 24-h period, and for the following time intervals: 20.00-00.00 h, 00.00-08.00 h and 08.00-18.00 h. Percentage time in the 24-h period with pH greater than 4.0 was also calculated.

Results: The two roxatidine regimens proved significantly superior to the placebo, decreasing 24-h acidity for all the time intervals, except the 20.00-00.00 h period, when mean intragastric pH with the early evening regimen (4.5 +/- 1.1) proved significantly higher than after placebo (2.2 +/- 1.0) or when roxatidine was taken at bedtime (2.4 +/- 1.1).

Conclusion: Early evening administration of roxatidine may afford satisfactory control of 24-h acidity, offering a useful alternative to conventional bedtime administration.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Administration Schedule
  • Duodenal Ulcer / drug therapy*
  • Female
  • Gastric Acid / metabolism*
  • Histamine H2 Antagonists / administration & dosage*
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Piperidines / administration & dosage*
  • Piperidines / therapeutic use

Substances

  • Histamine H2 Antagonists
  • Piperidines
  • roxatidine acetate